Literature DB >> 11675684

Osteodystrophy in posthepatitic cirrhosis.

M A Karan1, N Erten, C Tascioglu, A Karan, D Sindel, G Dilsen.   

Abstract

This study investigated the incidence and severity of hepatic osteodystrophy in patients with posthepatitic liver cirrhosis, and the role of hepatocellular injury in bone loss. Twenty-four patients (15 females and 9 males, mean age 49 +/- 13 years) with posthepatitic cirrhosis were enrolled in this study. The control group consisted of 22 healthy age and sex matched adults. The bone mineral density (BMD) was evaluated by dual energy x-ray absorptiometry of the L1-L4 vertebral bodies. A detailed questionnaire was used to assess the epidemiological findings. A statistically significant decrease in BMD of the patients was observed. There were no significant differences in the alkaline phosphatase, parathyroid hormone, calcitonin, 25-hydroxyvitamin D, osteocalcin, free testosterone, luteinizing hormone, follicle stimulating hormone, and estradiol levels, oral calcium intake, urinary calcium, phosphorus and hydroxypyroline excretion between patients and controls. The control group smoked more cigarettes, consumed more coffee and meat, and were exposed the sun light for a longer period than the study group. Multiple regression analysis showed that osteopenia depends significantly on the extent of liver disease. The data shows that the patients with posthepatitic cirrhosis had osteopenia, and that cirrhosis was a direct and independent risk factor.

Entities:  

Mesh:

Year:  2001        PMID: 11675684     DOI: 10.3349/ymj.2001.42.5.547

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  9 in total

1.  Clinical benefits of biochemical markers of bone turnover in Egyptian children with chronic liver diseases.

Authors:  Karam A Mahdy; Hanaa H Ahmed; Fathia Mannaa; Azza Abdel-Shaheed
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

2.  Hepatic osteodystrophy and liver cirrhosis.

Authors:  Vedat Goral; Mehmet Simsek; Nuriye Mete
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

3.  Hepatic osteodystrophy is common in patients with noncholestatic liver disease.

Authors:  N S Choudhary; M Tomar; Y K Chawla; S K Bhadada; N Khandelwal; R K Dhiman; A Duseja; A Bhansali
Journal:  Dig Dis Sci       Date:  2011-05-15       Impact factor: 3.199

4.  Bone mineral density in children with cirrhosis.

Authors:  Nuray Uslu; Inci Nur Saltik-Temizel; Hülya Demir; Yusuf Usta; Hasan Ozen; Figen Gürakan; Aysel Yüce; Nurten Koçak
Journal:  J Gastroenterol       Date:  2006-09       Impact factor: 7.527

Review 5.  Vitamin D deficiency in chronic liver disease.

Authors:  Paula Iruzubieta; Álvaro Terán; Javier Crespo; Emilio Fábrega
Journal:  World J Hepatol       Date:  2014-12-27

6.  Effects of cirrhosis on bone mineral density and bone metabolism.

Authors:  Mehmet Turkeli; Hakan Dursun; Fatih Albayrak; Nihat Okçu; M Hamidullah Uyanik; Abdullah Uyanik; Rahşan Yıldırım; Mustafa Keleş; Omer Yılmaz
Journal:  Eurasian J Med       Date:  2008-04

Review 7.  Osteoporosis and fractures in liver disease: relevance, pathogenesis and therapeutic implications.

Authors:  Inaam A Nakchbandi
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

8.  Bone mineral density and cytokine levels during interferon therapy in children with chronic hepatitis B: does interferon therapy prevent from osteoporosis?

Authors:  Ali Gur; Bünyamin Dikici; Kemal Nas; Mehmet Bosnak; Kenan Haspolat; Aysegul Jale Sarac
Journal:  BMC Gastroenterol       Date:  2005-09-19       Impact factor: 3.067

9.  Metabolic Bone Disease in Viral Cirrhosis: A Prospective Study.

Authors:  Rabia Goubraim; Nawal Kabbaj; Mouna Salihoun; Zakia Chaoui; M'Hamed Nya; Naima Amrani
Journal:  ISRN Hepatol       Date:  2013-04-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.